Annual Accounts Payable
$662.50 K
+$565.20 K+580.88%
December 31, 2023
Summary
- As of February 7, 2025, CRVO annual accounts payable is $662.50 thousand, with the most recent change of +$565.20 thousand (+580.88%) on December 31, 2023.
- During the last 3 years, CRVO annual accounts payable has risen by +$116.70 thousand (+21.38%).
- CRVO annual accounts payable is now -82.97% below its all-time high of $3.89 million, reached on December 1, 1999.
Performance
CRVO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.08 M
+$356.50 K+49.11%
September 30, 2024
Summary
- As of February 7, 2025, CRVO quarterly accounts payable is $1.08 million, with the most recent change of +$356.50 thousand (+49.11%) on September 30, 2024.
- Over the past year, CRVO quarterly accounts payable has increased by +$402.70 thousand (+59.25%).
- CRVO quarterly accounts payable is now -35.73% below its all-time high of $1.68 million, reached on December 1, 2016.
Performance
CRVO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CRVO Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +580.9% | +59.3% |
3 y3 years | +21.4% | +59.3% |
5 y5 years | +233.3% | +59.3% |
CRVO Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -30.1% | +580.9% | at high | +1012.4% |
5 y | 5-year | -47.1% | +580.9% | -23.3% | +1012.4% |
alltime | all time | -83.0% | +6525.0% | -35.7% | +2786.4% |
CervoMed Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.08 M(+49.1%) |
Jun 2024 | - | $725.90 K(+6.8%) |
Mar 2024 | - | $679.70 K(+2.6%) |
Dec 2023 | $662.50 K(+580.9%) | $662.50 K(+24.1%) |
Sep 2023 | - | $533.80 K(-42.7%) |
Jun 2023 | - | $932.40 K(-4.0%) |
Mar 2023 | - | $971.50 K(+898.5%) |
Dec 2022 | $97.30 K(-89.7%) | - |
Dec 2022 | - | $97.30 K(-87.9%) |
Sep 2022 | - | $807.40 K(-4.6%) |
Jun 2022 | - | $846.00 K(+4.0%) |
Mar 2022 | - | $813.20 K(-14.2%) |
Dec 2021 | $947.50 K(+73.6%) | $947.50 K(+39.7%) |
Sep 2021 | - | $678.00 K(-9.6%) |
Jun 2021 | - | $749.90 K(-21.3%) |
Mar 2021 | - | $952.90 K(+74.6%) |
Dec 2020 | $545.80 K(-56.4%) | $545.80 K(-61.3%) |
Sep 2020 | - | $1.41 M(+4.2%) |
Jun 2020 | - | $1.35 M(+106.8%) |
Mar 2020 | - | $655.30 K(-47.6%) |
Dec 2019 | $1.25 M(+529.5%) | $1.25 M(+149.0%) |
Sep 2019 | - | $502.50 K(+2.7%) |
Jun 2019 | - | $489.10 K(+1.9%) |
Mar 2019 | - | $480.00 K(+141.4%) |
Dec 2018 | $198.80 K(-61.2%) | $198.80 K(+54.0%) |
Sep 2018 | - | $129.10 K(-26.6%) |
Jun 2018 | - | $175.80 K(-58.1%) |
Mar 2018 | - | $419.10 K(-18.1%) |
Dec 2017 | $512.00 K(-69.6%) | $512.00 K(+25.1%) |
Sep 2017 | - | $409.40 K(-60.6%) |
Jun 2017 | - | $1.04 M(+86.3%) |
Mar 2017 | - | $557.60 K(-66.9%) |
Dec 2016 | $1.68 M(+296.6%) | $1.68 M(+122.3%) |
Sep 2016 | - | $757.50 K(-25.4%) |
Jun 2016 | - | $1.01 M(-9.4%) |
Mar 2016 | - | $1.12 M(+163.7%) |
Dec 2015 | $424.70 K | $424.70 K(+76.7%) |
Sep 2015 | - | $240.40 K(-28.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $337.60 K(+11.9%) |
Mar 2015 | - | $301.70 K(-27.7%) |
Dec 2014 | $417.30 K(-72.5%) | $417.30 K(+295.5%) |
Sep 2014 | - | $105.50 K(-58.2%) |
Jun 2014 | - | $252.10 K(-84.3%) |
Mar 2014 | - | $1.60 M(+5.4%) |
Dec 2013 | $1.52 M(+26.3%) | $1.52 M(-1.3%) |
Sep 2013 | - | $1.54 M(+13.7%) |
Jun 2013 | - | $1.35 M(+14.3%) |
Mar 2013 | - | $1.19 M(-1.5%) |
Dec 2012 | $1.20 M(+52.5%) | $1.20 M(+23.8%) |
Sep 2012 | - | $971.70 K(-7.7%) |
Jun 2012 | - | $1.05 M(+4.6%) |
Mar 2012 | - | $1.01 M(+27.6%) |
Dec 2011 | $789.00 K(-12.7%) | $789.00 K(+32.8%) |
Sep 2011 | - | $594.20 K(-5.2%) |
Jun 2011 | - | $627.10 K(-40.5%) |
Mar 2011 | - | $1.05 M(+16.6%) |
Dec 2010 | $903.30 K(+134.6%) | $903.30 K(+42.6%) |
Sep 2010 | - | $633.50 K(+13.7%) |
Jun 2010 | - | $557.30 K(+57.9%) |
Mar 2010 | - | $353.00 K(-8.3%) |
Dec 2009 | $385.00 K(-36.2%) | $385.00 K(-38.7%) |
Sep 2009 | - | $627.60 K(+2.4%) |
Jun 2009 | - | $613.00 K(-8.2%) |
Mar 2009 | - | $667.60 K(+10.7%) |
Dec 2008 | $603.20 K(-3.1%) | $603.20 K(+30.0%) |
Sep 2008 | - | $464.10 K(-25.7%) |
Jun 2008 | - | $624.80 K(+1.0%) |
Mar 2008 | - | $618.60 K(-0.6%) |
Dec 2007 | $622.40 K(+1559.7%) | $622.40 K(+654.4%) |
Sep 2007 | - | $82.50 K(+10.0%) |
Jun 2007 | - | $75.00 K(+100.0%) |
Mar 2007 | - | $37.50 K(0.0%) |
Dec 2006 | $37.50 K(+275.0%) | $37.50 K |
Dec 2005 | $10.00 K(-99.7%) | - |
Dec 1999 | $3.89 M(+25.5%) | - |
Dec 1998 | $3.10 M | - |
FAQ
- What is CervoMed annual accounts payable?
- What is the all time high annual accounts payable for CervoMed?
- What is CervoMed annual accounts payable year-on-year change?
- What is CervoMed quarterly accounts payable?
- What is the all time high quarterly accounts payable for CervoMed?
- What is CervoMed quarterly accounts payable year-on-year change?
What is CervoMed annual accounts payable?
The current annual accounts payable of CRVO is $662.50 K
What is the all time high annual accounts payable for CervoMed?
CervoMed all-time high annual accounts payable is $3.89 M
What is CervoMed annual accounts payable year-on-year change?
Over the past year, CRVO annual accounts payable has changed by +$565.20 K (+580.88%)
What is CervoMed quarterly accounts payable?
The current quarterly accounts payable of CRVO is $1.08 M
What is the all time high quarterly accounts payable for CervoMed?
CervoMed all-time high quarterly accounts payable is $1.68 M
What is CervoMed quarterly accounts payable year-on-year change?
Over the past year, CRVO quarterly accounts payable has changed by +$402.70 K (+59.25%)